L. Bras, J. Musset, L. Clain, and J. , Les r??sistances aux??m??dicaments antipaludiques, M??decine et Maladies Infectieuses, vol.36, issue.8, pp.401-405, 2006.
DOI : 10.1016/j.medmal.2006.05.005

N. White, Preventing antimalarial drug resistance through combinations, Drug Resistance Updates, vol.1, issue.1, pp.3-9, 2001.
DOI : 10.1016/S1368-7646(98)80208-2

R. Eastman and D. Fidock, Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria, Nature Reviews Microbiology, vol.7, pp.864-874, 2009.
DOI : 10.1038/nrmicro2239

V. Seidlein, L. Milligan, P. Pinder, M. Bojang, K. Anyalebechi et al., Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial, The Lancet, vol.355, issue.9201, pp.352-357, 2000.
DOI : 10.1016/S0140-6736(99)10237-X

P. Brasseur, P. Agnamey, O. Gaye, M. Vaillant, W. Taylor et al., Efficacy and safety of artesunate plus amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Senegal, Malaria Journal, vol.6, issue.1, p.150, 2007.
DOI : 10.1186/1475-2875-6-150

A. Yeka, G. Dorsey, M. Kamya, A. Talisuna, M. Lugemwa et al., Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treating Uncomplicated Malaria: A Randomized Trial to Guide Policy in Uganda, PLoS ONE, vol.360, issue.6, p.2390, 2008.
DOI : 10.1371/journal.pone.0002390.s002

E. Ashley, K. Lwin, R. Mcgready, W. Simon, L. Phaiphun et al., An open label randomized comparison of mefloquine?artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand, Tropical Medicine and International Health, vol.60, issue.11, pp.1653-1660, 2006.
DOI : 10.1016/S0140-6736(00)02505-8

S. Owusu-agyei, K. Asante, R. Owusu, M. Adjuik, S. Amenga-etego et al., An Open Label, Randomised Trial of Artesunate+Amodiaquine, Artesunate+Chlorproguanil-Dapsone and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria, PLoS ONE, vol.363, issue.1, p.2530, 2008.
DOI : 10.1371/journal.pone.0002530.s002

E. Arinaitwe, T. Sandison, H. Wanzira, A. Kahuru, J. Homsy et al., Artemether???Lumefantrine versus Dihydroartemisinin???Piperaquine for Falciparum Malaria: A Longitudinal, Randomized Trial in Young Ugandan Children, Clinical Infectious Diseases, vol.49, issue.11, pp.1629-1637, 2009.
DOI : 10.1086/647946

A. Tshefu, O. Gaye, K. Kayentao, R. Thompson, K. Bhatt et al., Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial, The Lancet, vol.375, issue.9724, pp.1457-1467, 2010.
DOI : 10.1016/S0140-6736(10)60322-4

V. Carrara, J. Zwang, E. Ashley, R. Price, K. Stepniewska et al., Changes in the Treatment Responses to Artesunate-Mefloquine on the Northwestern Border of Thailand during 13 Years of Continuous Deployment, PLoS ONE, vol.320, issue.2, p.4451, 2009.
DOI : 10.1371/journal.pone.0004551.t006

A. Dondorp, F. Nosten, P. Yi, D. Das, A. Phyo et al., Malaria, New England Journal of Medicine, vol.361, issue.5, pp.455-467, 2009.
DOI : 10.1056/NEJMoa0808859

URL : https://hal.archives-ouvertes.fr/hal-01199794

H. Noedl, Y. Se, K. Schaecher, B. Smith, D. Socheat et al., Evidence of Artemisinin-Resistant Malaria in Western Cambodia, New England Journal of Medicine, vol.359, issue.24, pp.2619-2620, 2008.
DOI : 10.1056/NEJMc0805011

W. Rogers, R. Sem, T. Tero, P. Chim, P. Lim et al., Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia, Malaria Journal, vol.8, issue.1, p.10, 2009.
DOI : 10.1186/1475-2875-8-10

F. Nawaz, S. Nsobya, M. Kiggundu, M. Joloba, and P. Rosenthal, Selection of Parasites with Diminished Drug Susceptibility by Amodiaquine???Containing Antimalarial Regimens in Uganda, The Journal of Infectious Diseases, vol.200, issue.11, pp.1650-1657, 2009.
DOI : 10.1086/647988

C. Lambros and J. Vanderberg, Synchronization of Plasmodium falciparum Erythrocytic Stages in Culture, The Journal of Parasitology, vol.65, issue.3, pp.418-420, 1979.
DOI : 10.2307/3280287

H. Bogreau, F. Renaud, H. Bouchiba, P. Durand, S. Assi et al., Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas, Am J Trop Med Hyg, vol.74, pp.953-959, 2006.

M. Henry, I. Diallo, J. Bordes, S. Ka, B. Pradines et al., Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates, Am J Trop Med Hyg, vol.75, pp.146-151, 2006.

B. Pradines, S. Briolant, M. Henry, C. Oeuvray, E. Baret et al., Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum, Malaria Journal, vol.9, issue.1, p.337, 2010.
DOI : 10.1186/1475-2875-9-339

S. Looareesuwan, D. Kyle, C. Vivaran, S. Vanijanonta, P. Wilairatana et al., Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand, Am J Trop Med Hyg, vol.54, pp.205-209, 1996.

P. Ringwald, M. Eboumbou, C. Bickii, J. Basco, and L. , In vitro activities of pyronaridine, alone and in combination with other antimalarial drugs, against Plasmodium falciparum, Antimicrob Agents Chemother, vol.43, pp.1525-1527, 1999.

F. Kurth, P. Pongratz, S. Bélard, B. Mordmüller, P. Kremsner et al., In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays, Malaria Journal, vol.8, issue.1, p.79, 2009.
DOI : 10.1186/1475-2875-8-79

B. Pradines, A. Tall, D. Parzy, A. Spiegel, T. Fusai et al., In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents., Journal of Antimicrobial Chemotherapy, vol.42, issue.3, pp.333-339, 1998.
DOI : 10.1093/jac/42.3.333

B. Pradines, M. Mamfoumbi, M. Parzy, D. , O. Medang et al., In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine, Am J Trop Med Hyg, vol.60, pp.105-108, 1999.

B. Pradines, A. Tall, F. Ramiandrasoa, A. Spiegel, C. Sokhna et al., In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum, Journal of Antimicrobial Chemotherapy, vol.57, issue.6, pp.1093-1099, 2006.
DOI : 10.1093/jac/dkl117

R. Price, J. Marfurt, F. Chalfein, E. Kenagalem, K. Piera et al., In Vitro Activity of Pyronaridine against Multidrug-Resistant Plasmodium falciparum and Plasmodium vivax, Antimicrobial Agents and Chemotherapy, vol.54, issue.12, pp.5146-5150, 2010.
DOI : 10.1128/AAC.00801-10

T. Davis, J. Hamzah, K. Ilett, H. Karunajeewa, J. Reeder et al., In Vitro Interactions between Piperaquine, Dihydroartemisinin, and Other Conventional and Novel Antimalarial Drugs, vitro interactions between piperaquine, dihydroartemisinin, and other conventional and novel antimalarial drugs, pp.2883-2885, 2006.
DOI : 10.1128/AAC.00177-06

L. Vivas, L. Rattray, L. Stewart, E. Bongard, B. Robinson et al., Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo, Acta Tropica, vol.105, issue.3, pp.222-228, 2008.
DOI : 10.1016/j.actatropica.2007.12.005

M. Ramharter, F. Kurth, A. Schreier, J. Nemeth, I. Glasenapp et al., Fixed???Dose Pyronaridine???Artesunate Combination for Treatment of Uncomplicated Falciparum Malaria in Pediatric Patients in Gabon, The Journal of Infectious Diseases, vol.198, issue.6, pp.911-919, 2008.
DOI : 10.1086/591096

G. Childs, B. Hausler, W. Milhous, C. Chen, T. Wimonwattrawatee et al., In vitro activity of pyronaridine against field isolates and reference clones of Plasmodium falciparum, Am J Trop Med Hyg, vol.38, pp.24-29, 1988.

B. Pradines, L. Bertaux, C. Pomares, P. Delaunay, and M. P. , Reduced in vitro susceptibility to artemisinin derivatives associated with multi-resistance in a traveller returning from South-East Asia, Malaria Journal, vol.10, issue.1, p.268, 2011.
DOI : 10.1128/AAC.45.6.1746-1750.2001

URL : https://hal.archives-ouvertes.fr/inserm-00629634

T. Davis, J. Hamzah, K. Illett, H. Karunajeewa, J. Reeder et al., In Vitro Interactions between Piperaquine, Dihydroartemisinin, and Other Conventional and Novel Antimalarial Drugs, vitro interactions between piperaquine, dihydroartemisinin, and other conventional and novel antimalarial drugs, pp.2883-2885, 2006.
DOI : 10.1128/AAC.00177-06

Q. Fivelman, I. Adagu, and D. Warhurst, Effects of Piperaquine, Chloroquine, and Amodiaquine on Drug Uptake and of These in Combination with Dihydroartemisinin against Drug-Sensitive and -Resistant Plasmodium falciparum Strains, Antimicrobial Agents and Chemotherapy, vol.51, issue.6, pp.2265-2267, 2007.
DOI : 10.1128/AAC.01479-06

S. Muangnoicharoen, D. Johnson, S. Looareesuwan, S. Krudsood, and S. Ward, Role of Known Molecular Markers of Resistance in the Antimalarial Potency of Piperaquine and Dihydroartemisinin In Vitro, Antimicrobial Agents and Chemotherapy, vol.53, issue.4, pp.1362-1366, 2009.
DOI : 10.1128/AAC.01656-08

C. Snyder, J. Chollet, J. Santo-tomas, C. Scheurer, and S. Wittlin, In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models, Experimental Parasitology, vol.115, issue.3, pp.296-300, 2007.
DOI : 10.1016/j.exppara.2006.09.016

J. Tarning, E. Ashley, N. Lindegardh, K. Stepniewska, L. Phaiphun et al., Population Pharmacokinetics of Piperaquine after Two Different Treatment Regimens with Dihydroartemisinin-Piperaquine in Patients with Plasmodium falciparum Malaria in Thailand, Antimicrobial Agents and Chemotherapy, vol.52, issue.3, pp.1052-1061, 2008.
DOI : 10.1128/AAC.00955-07

N. Valecha, P. Phyo, A. Mayxay, M. Newton, P. Krudsood et al., An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia, PLoS ONE, vol.7, issue.7, p.11880, 2010.
DOI : 10.1371/journal.pone.0011880.s009

T. Grande, A. Bernasconi, A. Erhart, D. Gamboa, M. Casapia et al., A randomized controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru, PLoS One, vol.10, p.1101, 2007.

G. Awab, S. Pukrittayakamee, M. Imwong, A. Dondorp, C. Woodrow et al., Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial, Malaria Journal, vol.9, issue.1, p.105, 2010.
DOI : 10.1186/1475-2875-9-105

T. Davis, T. Hung, I. Sim, H. Karunajeewa, and K. Ilett, Piperaquine, Drugs, vol.7, issue.1, pp.75-87, 2005.
DOI : 10.2165/00003495-200565010-00004

S. Briolant, M. Henry, C. Oeuvray, R. Amalvict, E. Baret et al., Absence of Association between Piperaquine In Vitro Responses and Polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe Genes in Plasmodium falciparum, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.3537-3544, 2010.
DOI : 10.1128/AAC.00183-10

L. Basco and P. Ringwald, In Vitro Activities of Piperaquine and Other 4-Aminoquinolines against Clinical Isolates of Plasmodium falciparum in Cameroon, Antimicrobial Agents and Chemotherapy, vol.47, issue.4, pp.1391-1394, 2003.
DOI : 10.1128/AAC.47.4.1391-1394.2003

M. Barends, A. Jaidee, N. Khaohirun, P. Singhasivanon, and F. Nosten, In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border, Malaria Journal, vol.6, issue.1, p.81, 2007.
DOI : 10.1186/1475-2875-6-81

L. Mwai, S. Kiara, A. Abdirahman, L. Pole, A. Rippert et al., In Vitro Activities of Piperaquine, Lumefantrine, and Dihydroartemisinin in Kenyan Plasmodium falciparum Isolates and Polymorphisms in pfcrt and pfmdr1, Antimicrobial Agents and Chemotherapy, vol.53, issue.12, pp.5069-5073, 2009.
DOI : 10.1128/AAC.00638-09

S. Nsobya, M. Kiggundu, S. Nanyunja, M. Joloba, B. Greenhouse et al., In Vitro Sensitivities of Plasmodium falciparum to Different Antimalarial Drugs in Uganda, Antimicrobial Agents and Chemotherapy, vol.54, issue.3, pp.1200-1206, 2010.
DOI : 10.1128/AAC.01412-09

J. Marfurt, F. Chalfein, P. Prayoga, F. Wabiser, E. Kenangalem et al., Ex Vivo Drug Susceptibility of Ferroquine against Chloroquine-Resistant Isolates of Plasmodium falciparum and P. vivax, Antimicrobial Agents and Chemotherapy, vol.55, issue.9, pp.4461-4464, 2011.
DOI : 10.1128/AAC.01375-10

R. Wong, D. Lautu, L. Tavul, S. Hackett, P. Siba et al., to conventional and novel antimalarial drugs in Papua New Guinea, Tropical Medicine & International Health, vol.2, issue.Suppl. 4, pp.342-349, 2010.
DOI : 10.1111/j.1365-3156.2009.02463.x

R. Eastman, N. Dharia, E. Winzeler, and D. Fidock, Piperaquine resistance is associated with a copy number variation on chromosome 5 in

H. Myint, E. Ashley, N. Day, F. Nosten, and N. White, Efficacy and safety of dihydroartemisinin-piperaquine, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.101, issue.9, pp.858-866, 2007.
DOI : 10.1016/j.trstmh.2007.05.018

R. Price, A. Hasugian, A. Ratcliff, H. Siswantoro, H. Purba et al., Clinical and Pharmacological Determinants of the Therapeutic Response to Dihydroartemisinin-Piperaquine for Drug-Resistant Malaria, Antimicrobial Agents and Chemotherapy, vol.51, issue.11, pp.4090-4097, 2007.
DOI : 10.1128/AAC.00486-07

M. Kamya, A. Yeka, H. Burkirwa, M. Lugemwa, J. Rwakimari et al., Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial, PLoS Clinical Trials, vol.2, issue.5, p.20, 2007.
DOI : 10.1371/journal.pctr.0020020.sd002

I. Zongo, G. Dorsey, N. Rouamba, C. Dokomajilar, Y. Séré et al., Randomized Comparison of Amodiaquine plus Sulfadoxine-Pyrimethamine, Artemether-Lumefantrine, and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Burkina Faso, Clinical Infectious Diseases, vol.45, issue.11, pp.1453-1461, 2007.
DOI : 10.1086/522985

A. Hasugian, H. Purba, E. Kenangalem, R. Wuwung, E. Ebsworth et al., Dihydroartemisinin-Piperaquine versus Artesunate-Amodiaquine: Superior Efficacy and Posttreatment Prophylaxis against Multidrug-Resistant Plasmodium falciparum and Plasmodium vivax Malaria, Clinical Infectious Diseases, vol.44, issue.8, pp.1067-1074, 2008.
DOI : 10.1086/512677

H. Karunajeewa, K. Ilett, I. Mueller, P. Siba, I. Law et al., Pharmacokinetics and Efficacy of Piperaquine and Chloroquine in Melanesian Children with Uncomplicated Malaria, Antimicrobial Agents and Chemotherapy, vol.52, issue.1, pp.237-243, 2008.
DOI : 10.1128/AAC.00555-07

J. Tarning, N. Lindegardh, A. Annerberg, T. Singtoroj, N. Day et al., Pitfalls in Estimating Piperaquine Elimination, Antimicrobial Agents and Chemotherapy, vol.49, issue.12, pp.5127-5128, 2005.
DOI : 10.1128/AAC.49.12.5127-5128.2005

F. Ezzet, R. Mull, and J. Karbwang, Population pharmacokinetics and therapeutic response of CGP 56697 (artemether+benflumetol) in malaria patients, British Journal of Clinical Pharmacology, vol.41, issue.6
DOI : 10.1046/j.1365-2125.1998.00830.x